TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 SEK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
845
|
970 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
100
|
346 | |
EBITDA |
100
|
346 | |
Total assets |
625
|
643 | |
Current assets |
625
|
643 | |
Current liabilities |
121
|
239 | |
Equity capital |
502
|
402 | |
- share capital |
150
|
50 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
80.3%
|
62.5% | |
Turnover per employee |
845
|
970 | |
Profit as a percentage of turnover |
11.8%
|
35.7% | |
Return on assets (ROA) |
16.0%
|
53.8% | |
Current ratio |
516.5%
|
269.0% | |
Return on equity (ROE) |
19.9%
|
86.1% | |
Change turnover |
-125
|
185 | |
Change turnover % |
-100%
|
-13%
|
24% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.